🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
0.8805
-0.0208 (-2.31%)
Nov 18, 2026, 12:57 PM EST - Market open

Spero Therapeutics Revenue

Spero Therapeutics had revenue of $41.56M in the twelve months ending September 30, 2026, up 2.48% year-over-year. In the year 2025, Spero Therapeutics had annual revenue of $66.80M with 39.24% growth. That makes Spero Therapeutics the 29,314th largest company in the world by revenue and 3,895th in the United States.

Revenue (ttm)
$41.56M
Revenue Growth
+2.48%
P/S Ratio
1.26
Revenue / Employee
$1,662,200
Employees
25
Market Cap
51.28M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202566.80M18.83M39.24%
Dec 31, 202447.98M-55.80M-53.77%
Dec 31, 2023103.78M50.27M93.95%
Dec 31, 202253.51M35.25M193.10%
Dec 31, 202118.26M8.93M95.67%
Dec 31, 20209.33M-8.82M-48.59%
Dec 31, 201918.15M14.18M357.56%
Dec 31, 20183.97M1.99M100.40%
Dec 31, 20171.98M1.64M490.75%
Dec 31, 2016335.00K--
Dec 31, 2015---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.